19 October-1 December 2020
The 51st Union World Conference On Lung Health


All Sessions
keyboard_arrow_down Show filters keyboard_arrow_up Hide filters
  • All Tracks
  • Community Connect
  • Channel 1
  • Channel 2
  • Channel 3
  • Channel 4
  • Channel 5
  • Channel 6
  • Channel 7
  • E-posters
  • Workshops
Channel 7
TBS4B-Innovations in TB therapeutics: oral abstract presentations
query_builder 16:30 - 17:12 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel TBScience session
mic English
TBS4B-Innovations in TB therapeutics: oral abstract presentations
*Please scroll down for more information*
Tuberculosis (TB) therapeutics research is experiencing a renaissance with an increasing number of new compounds, innovative tools and strategies undergoing evaluation as part of novel regimen development. This is welcome progress as the field seeks to address the long durations of treatment, toxicities, drug–drug interactions and high costs of current therapies. This session will highlight the potential of therapeutic vaccines, innovative tools for regimen development and genomic discoveries with relevance to development of host-directed therapies for curing TB.

16:30 - 16:32: Session introduction

16:32 - 16:40: TBS-OA-13-An empirical modeling approach for regimen development: How to build a winning team.

Natasha Strydom

16:40 - 16:48: TBS-OA-14-The role of respiratory microbiome in early bactericidal activity of anti-tuberculosis therapy and treatment outcome

Wilber Sabiiti

16:48 - 16:56: TBS-OA-15-In silico assessment of adaptive trial design for TB regimen development

Vincent Chang

16:56 - 17:04: TBS-OA-16-Translational platform for predicting clinical outcomes for new combination regimens using pre-clinical and phase I data

Qianwen Wang

17:04 - 17:12: Live Q&A

Processing. Please wait.